The invention refers to substituted 6-(thien-2-yl)-3(2H)-pyridazinones of Formula I ##STR1##
这项发明涉及Formula I的取代6-(噻吩-2-基)-3(2H)-吡啶并酮。
Imidazole group containing 2(1H)-pyridones and method for treating heart
申请人:A. Nattermann & Cie GmbH
公开号:US04699914A1
公开(公告)日:1987-10-13
The present invention is directed to new, an imidazole group containing 2(1H)-pyridones of formula I ##STR1## salts thereof and process for treating congestive heart failure in humans.
本发明涉及一种新的,含有咪唑基的公式I的2(1H)-吡啶酮,其盐以及治疗人类充血性心力衰竭的方法。
Substituted 6-(thien-2-yl)-3(2H)-pyridazinones and processes for their preparation
申请人:A. Nattermann & Cie. GmbH
公开号:EP0128502A1
公开(公告)日:1984-12-19
The invention refers to substituted 6-(thien-2-yl)-3(2H)-pyridazinones of formula I
and processes for their preparation.
本发明涉及式 I 的取代 6-(噻吩-2-基)-3(2H)-哒嗪酮及其制备方法。
及其制备工艺。
Substituted 4.5-dihydro-6-vinyl-3(2H)-pyridazinones and 6-vinyl-3(2H)-pyridazinones and process for producing the same
申请人:A. Nattermann & Cie. GmbH
公开号:EP0150463A1
公开(公告)日:1985-08-07
The invention is related to new substituted 4.5-dihydro-6-vinyl-3(2H)-pyridazinones and 6-vinyl-3(2H)-pyridazinones of the formula I
as well as to processes for producing the same.
本发明涉及新的取代的 4.5-二氢-6-乙烯基-3(2H)-哒嗪酮和式 I 的 6-乙烯基-3(2H)-哒嗪酮,以及生产它们的工艺。
及其生产工艺。
Neue, eine Imidazol-gruppe enthaltende 3,4-Dihydro-2(1H)-Pyridone und 2(1H)-Pyridone, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
申请人:A. Nattermann & Cie. GmbH
公开号:EP0175187A1
公开(公告)日:1986-03-26
Gegenstand der vorliegenden Erfindung sind neue, eine Imidazol-Gruppe enthaltende 3,4-Dihydro-2(1H)-pyridone und 2(1 H)-Pyridone der Formel 1,
jeren Salze, Verfahren zu ihrer Herstellung sowie diese enthal- :ende Arzneimittel.